Genome instability is a potentially lethal event for a eukaryotic cell, and a mutational force for genetic diseases such as cancer. DNA double-strand breaks (DSBs) can drive genome instability and are sensed by the DNA damage checkpoint, a defined set of evolutionarilyconserved proteins that bind the DSB to signal a pause or arrest of the cell cycle 1 and recruit proteins to repair the DNA lesion 2,3 . Telomeres, the physical ends of linear eukaryotic chromosomes, are specialized DSBs that suppress DNA damage checkpoint activation by an unknown mechanism(s), even though telomeres are bound by many of the DNA damage checkpoint proteins that signal cell cycle arrest 4 . Carneiro et al. 
addressed this question using Schizosaccharomyces pombe cells that lack Taz1, the protein that binds to double-stranded telomere repeats 5 . Telomeres in taz1∆ cells have single-stranded DNA regions that are bound by checkpoint and DNA repair proteins, but cells do not arrest 5, 6 .
Carneiro et al. found that the ortholog of the human DNA damage checkpoint protein 53BP1 (Crb2) found at DSBs was not recruited to telomeres 5 . Crb2 can bind to dimethylated lysine 20 of histone H4 (H4K20me2) in nucleosomes 7 . Carneiro et al. presented data that H4K20me2 was depleted near telomeres in wild type and taz1∆ cells, suggesting a mechanism for checkpoint suppression 5 . Our efforts to pursue this exciting result led to the discovery that H4K20me2 is not depleted near telomeres, indicating that checkpoint suppression occurs by some other mechanism(s).
H4K20me2 constitutes ~25% of total H4 in S. pombe 8 , implicating a telomere-associated demethylase to deplete H4K20me2 at telomeres in taz1∆ cells to prevent checkpoint-mediated arrest. However, both a genome-wide screen of gene deletion mutants (D. Durocher, pers.
comm.) and our screen of demethylase mutants failed to identify a mutant that caused taz1∆ cells to arrest, to grow poorly or to recruit more Crb2. We therefore re-evaluated H4K20me2 levels by chromatin immunoprecipitation (ChIP). We first identified commercial antibodies methyl groups (set9-F195Y) were also assayed 10 . The specific antibody identified (Fig. 1A ) was used in ChIP to monitor H4K20me2 at the telomeric loci assayed in Carneiro et al. and two internal chromosomal loci in wild type and taz1∆ cells, and in mutants that lack H4K20 methylation, set9∆ and H4K20R. Total H4 levels at these loci were monitored with an antibody that recognizes all H4 forms.
We found that H4K20me2 levels are similar at all three loci in wild type and taz1∆ cells, and clearly distinguishable from the set9∆ and H4K20R negative controls (Fig. 1B) . These data argue that while the damaged telomeres in taz1∆ cells block checkpoint activation, the mechanism that hinders Crb2 recruitment is unlikely to be the suppression of H4K20me2 in telomeric chromatin. These results and conclusion are consistent with the genetic screen results that did not identify a demethylase required to sever the checkpoint in taz1∆ cells, and suggest that searches for combinations of demethylase mutants that activate the checkpoint in taz1∆ cells will not be fruitful. Rather, broader approaches to investigate the differences between telomeres and DSBs may be required, including much more extensive characterization of the post-translation modifications of proteins at or near telomeres. While H4K20me2 levels
are not reduced at telomeres, it is worth noting that checkpoint activation is the sum of multiple protein interactions and modifications, e.g. phosphorylation of histone H2A and modification of several checkpoint proteins 11, 12 . Reducing the efficiency of several of these interactions may be sufficient to impair checkpoint signaling at taz1∆ cell telomeres. Results from such studies may provide an understanding of the anti-checkpoint activity of telomeres so that it may be modulated to treat telomere-related diseases such as cellular aging and cancer 13 .
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